arrow
J

John K. Field

University of Liverpool
H指数:100
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI Performance for Nodule Volume Doubling Time in the follow-up of the UKLS Lung Cancer Screening Study Compared to Expert Consensus and Histological Validation

AI在UKLS肺癌筛查研究中用于结节体积倍增时间的随访表现,与专家共识及组织学验证的比较

2025-11-220
OAAI
Assessing PD-L1 expression in non-small cell lung carcinoma: a prospective study of matched fine-needle aspirates, core biopsies, and resection specimens using alcohol and forming fixatives

评估非小细胞肺癌中PD-L1的表达:一项使用酒精和甲醛固定剂对匹配的细针抽吸物、核心活检和切除标本进行的前瞻性研究

2025-08-250
OAAI
Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium

早期非小细胞肺癌预后的全基因组关联研究:国际肺癌研究协作组的一项合并分析

2025-08-010
PRE
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci

6531名非裔美国人肺癌的全基因组关联研究揭示了新的易感基因位点

2025-05-080
PRE
Lung Cancer Screening Program Quality Indicators—Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process Study

肺癌筛查项目质量指标—综述与建议:一项国际肺癌研究协会德尔菲流程研究

2025-01-240
OAAI
Response to the Letters to the Editor by Jing Peng and Colleagues and by Lauren C Leiman Regarding the Manuscript Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations

对Jing Peng及其同事以及Lauren C Leiman关于肺癌筛查和早期检测中术语问题的手稿的致编辑信的回应—国际肺癌研究协会早期检测和筛查委员会专家小组建议

2025-01-010
PRE
Radiotherapy (RT) patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients (pts) with Stage III unresectable non-small cell lung cancer (UR-NSCLC) treated with durvalumab (D) after chemoradiotherapy (CRT)

放射治疗(RT)模式及与PACIFIC-R研究中肺炎相关的因素,该研究是一项真实世界研究,研究对象为接受化疗放疗(CRT)后使用度伐利尤单抗(D)治疗的III期不可切除非小细胞肺癌(UR-NSCLC)患者(pts)。

2024-09-010
PRE
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

不可切除的III期NSCLC患者放化疗后durvalumab的真实世界结局: PACIFIC-R的总生存期中期分析

2024-06-017
OAAI
Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification

个体水平肺癌多基因风险不确定度评分 (PRS) 对危险分层的影响

2024-02-051
OAAI
Occupational Benzene Exposure and Lung Cancer Risk A Pooled Analysis of 14 Case-Control Studies
2024-01-158
OA
Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

永远和从不吸烟者的肺癌: 多人群gis研究的发现

2024-01-053
OA
Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY)
2024-01-016
OAAI
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility

CYP2A6活性与吸烟相关肺癌易感性的相互作用

2023-12-201
PRE
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls

在34,964病例和448,579对照中鉴定与非小细胞肺癌风险相关的遗传预测的DNA甲基化标记

CANCER
IF5.1
2023-12-060
OAAI